“Transcription Factor ASCL1 Targets SLC6A13 to Inhibit the Progression of Hepatocellular Carcinoma via the Glycine-Inflammasome Signaling”. 2024. Biomolecules and Biomedicine, May. https://doi.org/10.17305/bb.2024.10328.